Virtually Unstoppable: A Global Experience
This year’s virtual Summit & Gala has proven that FAST truly is global. Over 1,700 people from 61 countries around the world tuned in to FAST&rsquo
The Next Frontier in FAST Funded Research
For 12 years FAST has been working diligently to fundraise, identify research opportunities, and wisely invest in science in order to develop real and effect
FAST Italy: educating the Italian community and contributing to global research
Benedetta Sirtori with son Pier Luigi Today, FAST Italy is proud that their country’s first clinical trial for Angelman syndrome (AS), Roche’s Tangelo tr
FAST Australia – Building Community and Finding a Cure
FAST Australia, one of the first branches of FAST, was founded in 2010 by a group of determined and dedicated parents of children with Angelman syndrome (AS)
Diagnosis, an odyssey in developing countries
FAST collaborates with Casa Angelman on quest to provide diagnostic services throughout Argentina and South America As FAST continues to grow, we are fortuna
Pilot Feasibility of an Enzyme Replacement Therapy for AS
FAST and FAST Canada are pleased to announce a grant to UC Davis. David Segal, Ph.D. and his UC Davis lab have received funding to determine if enzyme repl
Rodent Studies of Non-Snord 116 Paternal Ube3a Activation
FAST and FAST Canada are pleased to announce grant funding to David Segal, Ph.D. and his UC Davis lab to investigate targeting the Ube3a-AS (Ube3a Antisense
Adult Transition: Meet Juli & Tracy
Juli DelMonego is mom to 3 sons, and her 32 year old daughter Marina with AS. Juli started early learning about disability rights, researching Special Educat
An interview with Dr. David Segal on the UC Davis center and the future of gene editing as therapy
Barb Bailus, PhD David Gurzick, PhD Hello Everyone! Today we have a very special guest with us, Dr. Dave Segal! He is joining us to discuss the amazing new n
Part II: CRISPR for Angelman syndrome
David Gurzick, PhD Barb Bailus, PhD In a recent post, we introduced gene editing technologies with a focus on CRISPR (haven’t seen it? – it’s available